Latest Posts

India’s healthcare industry to reach $372 bn by 2022: NITI Aayog

[ad_1]

India’s healthcare industry has been growing at a compound annual growth rate of around 22 per cent since 2016 and is expected to reach $372 billion in 2022 at this rate, a NITI Aayog report said on Tuesday.

Healthcare has become one of the largest sectors of the Indian economy, in terms of both revenue and employment, said the report released by NITI Aayog’s Member, Health, V.K. Paul, CEO Amitabh Kant, and Additional Secretary Rakesh Sarwal.

The report outlines the range of investment opportunities in various segments of India’s healthcare sector, including hospitals, medical devices and equipment, health insurance, telemedicine, home healthcare and medical value travel.

“Several factors are driving the growth of the Indian healthcare sector, including an aging population, a growing middle class, the rising proportion of lifestyle diseases, an increased emphasis on public-private partnerships as well as accelerated adoption of digital technologies,” Kant wrote in the report’s foreword.

“The Covid-19 pandemic has not only presented challenges but also several opportunities for India to grow. All these factors, together make India’s healthcare industry ripe for investment.”

In the first section, the report provides an overview of India’s healthcare sector, including insights about its employment generation potential, the prevailing business and investment climate as well as the overarching policy landscape.

The second section highlights the key drivers of growth for the sector and the third elaborates upon the enabling policies and investment opportunities in seven key segments – hospitals and infrastructure, health insurance, pharmaceuticals and biotechnology, medical devices, medical tourism, home healthcare as well as telemedicine and other technology-related health services.

In the hospital segment, the expansion of private players to tier-2 and tier-3 locations, beyond metropolitan cities, offers an attractive investment opportunity, it says.

With respect to pharmaceuticals, the report said, India can boost domestic manufacturing, supported by recent government schemes with performance-linked incentives, as part of the Aatmanirbhar Bharat initiative.

In the medical devices and equipment segment, it said, expansion of diagnostic and pathology centres as well as miniaturised diagnostics have high potential for growth.

Further, medical value travel, especially wellness tourism, has bright prospects, given India’s inherent strengths in alternative systems of medicine, said the report.

“Technology advancements such as Artificial Intelligence (AI), wearables and other mobile technologies, along with Internet of Things, also offer numerous avenues for investment.”

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Posts

Don't Miss

Stay in touch

To be updated with all the latest news, offers and special announcements.